Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Check out the new look and feel of Harvard Catalyst Profiles! Learn more on our About and Help pages.

Richard George Marlink, M.D.

Title
Institution
Department
Address
Phone
Profile Picture

Mentoring
Barriers to Effective Treatment for People with HIV and AIDS in Northern Thailand
Full Time/Year Long, 01/15/00 - 07/15/00
A Universal Antiretroviral Therapy Program in a Developing Country: the Experience of Botswana
International/Summer, 06/23/03 - 08/31/03
A Universal Antiretroviral Therapy Program in a Developing Country: the Experience of Botswana
International/Summer, 06/23/03 - 08/31/03

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01AI052032 (MARLINK, RICHARD GEORGE) Mar 1, 2003 - Aug 31, 2007
    NIH/NIAID
    Cost-Effectiveness of HAART for HIV and AIDS in Botswana
    Role: Principal Investigator
  2. P01AI030795 (KANKI, PHYLLIS J.) Sep 30, 1990 - Jul 31, 1995
    NIH/NIAID
    NATURAL HISTORY OF HIV INFECTIONS IN SENEGAL
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Diphoko T, Gaseitsiwe S, Kasvosve I, Moyo S, Okatch H, Musonda R, Wainberg M, Makhema J, Marlink R, Novitsky V, Essex M. Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana. AIDS Res Hum Retroviruses. 2018 Jun 12. PMID: 29732907.
    View in: PubMed
  2. Mupfumi L, Moyo S, Molebatsi K, Thami PK, Anderson M, Mogashoa T, Iketleng T, Makhema J, Marlink R, Kasvosve I, Essex M, Musonda RM, Gaseitsiwe S. Correction: Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana. PLoS One. 2018; 13(6):e0198711. PMID: 29856867.
    View in: PubMed
  3. Mupfumi L, Moyo S, Molebatsi K, Thami PK, Anderson M, Mogashoa T, Iketleng T, Makhema J, Marlink R, Kasvosve I, Essex M, Musonda RM, Gaseitsiwe S. Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana. PLoS One. 2018; 13(1):e0192030. PMID: 29385208.
    View in: PubMed
  4. N'Guessan KF, Anderson M, Phinius B, Moyo S, Malick A, Mbangiwa T, Choga WT, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT. The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana. Open Forum Infect Dis. 2017; 4(4):ofx222. PMID: 29255726.
    View in: PubMed
  5. Ryan K, Anderson M, Gyurova I, Ambroggio L, Moyo S, Sebunya T, Makhema J, Marlink R, Essex M, Musonda R, Gaseitsiwe S, Blackard JT. High Rates of Occult Hepatitis B Virus Infection in HIV-Positive Individuals Initiating Antiretroviral Therapy in Botswana. Open Forum Infect Dis. 2017; 4(4):ofx195. PMID: 29062862.
    View in: PubMed
  6. Marlink R. Urgently Creating the Better in Global Health. Hastings Cent Rep. 2017 Sep; 47(5):25-26. PMID: 28940350.
    View in: PubMed
  7. Campa A, Baum MK, Bussmann H, Martinez SS, Farahani M, van Widenfelt E, Moyo S, Makhema J, Essex M, Marlink R. The effect of micronutrient supplementation on active TB incidence early in HIV infection in Botswana. Nutr Diet Suppl. 2017; 2017(9):37-45. PMID: 29187783.
    View in: PubMed
  8. Xie W, Agniel D, Shevchenko A, Malov SV, Svitin A, Cherkasov N, Baum MK, Campa A, Gaseitsiwe S, Bussmann H, Makhema J, Marlink R, Novitsky V, Lee TH, Cai T, O'Brien SJ, Essex M. Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa. AIDS Res Hum Retroviruses. 2017 06; 33(6):597-609. PMID: 28132517.
    View in: PubMed
  9. Moyo S, Kotokwe KP, Mohammed T, Boleo C, Mupfumi L, Chishala S, Tsalaile L, Bussmann H, Gaseitsiwe S, Musonda R, Makhema J, Baum M, Marlink R, Engelbrecht S, Essex M, Novitsky V. Short Communication: Low False Recent Rate of Limiting Antigen-Avidity Assay Combined with HIV-1 RNA Data in Botswana. AIDS Res Hum Retroviruses. 2017 01; 33(1):17-18. PMID: 27481530.
    View in: PubMed
  10. Anderson M, Gaseitsiwe S, Moyo S, Thami KP, Mohammed T, Setlhare D, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM. Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana. Open Forum Infect Dis. 2016 Sep; 3(3):ofw140. PMID: 27800524.
    View in: PubMed
  11. Farahani M, Price N, El-Halabi S, Mlaudzi N, Keapoletswe K, Lebelonyane R, Fetogang EB, Chebani T, Kebaabetswe P, Masupe T, Gabaake K, Auld AF, Nkomazana O, Marlink R. Impact of Health System Inputs on Health Outcome: A Multilevel Longitudinal Analysis of Botswana National Antiretroviral Program (2002-2013). PLoS One. 2016; 11(8):e0160206. PMID: 27490477; PMCID: PMC4974006.
  12. Auld AF, Blain M, Ekra KA, Kouakou JS, Ettiègne-Traoré V, Tuho MZ, Mohamed F, Shiraishi RW, Sabatier J, Essombo J, Adjorlolo-Johnson G, Marlink R, Ellerbrock TV. Wide Variations in Compliance with Tuberculosis Screening Guidelines and Tuberculosis Incidence between Antiretroviral Therapy Facilities - Côte d'Ivoire. PLoS One. 2016; 11(6):e0157059. PMID: 27275742; PMCID: PMC4898722.
  13. Martinez SS, Campa A, Bussmann H, Moyo S, Makhema J, Huffman FG, Williams OD, Essex M, Marlink R, Baum MK. Effect of BMI and fat mass on HIV disease progression in HIV-infected, antiretroviral treatment-naïve adults in Botswana. Br J Nutr. 2016 06; 115(12):2114-21. PMID: 27087233.
    View in: PubMed
  14. Farahani M, Novitsky V, Wang R, Bussmann H, Moyo S, Musonda RM, Moeti T, Makhema JM, Essex M, Marlink R. Prognostic Value of HIV-1 RNA on CD4 Trajectories and Disease Progression Among Antiretroviral-Naive HIV-Infected Adults in Botswana: A Joint Modeling Analysis. AIDS Res Hum Retroviruses. 2016 06; 32(6):573-8. PMID: 26830351; PMCID: PMC4892219 [Available on 06/01/17].
  15. Ahmed S, Bärnighausen T, Daniels N, Marlink R, Roberts MJ. How providers influence the implementation of provider-initiated HIV testing and counseling in Botswana: a qualitative study. Implement Sci. 2016 Feb 11; 11:18. PMID: 26864321; PMCID: PMC4750298.
  16. Farahani M, Mulinder H, Farahani A, Marlink R. Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis. Int J STD AIDS. 2017 06; 28(7):636-650. PMID: 26868158.
    View in: PubMed
  17. Farahani M, Price N, El-Halabi S, Mlaudzi N, Keapoletswe K, Lebelonyane R, Fetogang EB, Chebani T, Kebaabetswe P, Masupe T, Gabaake K, Auld A, Nkomazana O, Marlink R. Trends and determinants of survival for over 200?000 patients on antiretroviral treatment in the Botswana National Program: 2002-2013. AIDS. 2016 Jan 28; 30(3):477-85. PMID: 26636931; PMCID: PMC4711385.
  18. Baum MK, Campa A, Page JB, Lai S, Tsalaile L, Martinez SS, Burns P, Williams O, Li Y, van Widenfelt E, Bussmann H, Sikhulele M, Makhema J, Essex M, Marlink R. Recruitment, Follow-Up and Characteristics of HIV Infected Adults who Use Illicit Drugs in Southern Africa. J Drug Abuse. 2015; 1(1). PMID: 26855969.
    View in: PubMed
  19. Auld AF, Shiraishi RW, Mbofana F, Couto A, Fetogang EB, El-Halabi S, Lebelonyane R, Pilatwe PT, Hamunime N, Okello V, Mutasa-Apollo T, Mugurungi O, Murungu J, Dzangare J, Kwesigabo G, Wabwire-Mangen F, Mulenga M, Hachizovu S, Ettiegne-Traore V, Mohamed F, Bashorun A, Nhan do T, Hai NH, Quang TH, Van Onacker JD, Francois K, Robin EG, Desforges G, Farahani M, Kamiru H, Nuwagaba-Biribonwoha H, Ehrenkranz P, Denison JA, Koole O, Tsui S, Torpey K, Mukadi YD, van Praag E, Menten J, Mastro TD, Hamilton CD, Abiri OO, Griswold M, Pierre E, Xavier C, Alfredo C, Jobarteh K, Letebele M, Agolory S, Baughman AL, Mutandi G, Preko P, Ryan C, Ao T, Gonese E, Herman-Roloff A, Ekra KA, Kouakou JS, Odafe S, Onotu D, Dalhatu I, Debem HH, Nguyen DB, Yen le N, Abdul-Quader AS, Pelletier V, Williams SG, Behel S, Bicego G, Swaminathan M, Dokubo EK, Adjorlolo-Johnson G, Marlink R, Lowrance D, Spira T, Colebunders R, Bangsberg D, Zee A, Kaplan J, Ellerbrock TV. Lower Levels of Antiretroviral Therapy Enrollment Among Men with HIV Compared with Women - 12 Countries, 2002-2013. MMWR Morb Mortal Wkly Rep. 2015 Nov 27; 64(46):1281-6. PMID: 26605861.
    View in: PubMed
  20. Farahani M, Price N, El-Halabi S, Mlaudzi N, Keapoletswe K, Lebelonyane R, Fetogang EB, Chebani T, Kebaabetswe P, Masupe T, Gabaake K, Auld A, Nkomazana O, Marlink R. Variation in attrition at subnational level: review of the Botswana National HIV/AIDS Treatment (Masa) programme data (2002-2013). Trop Med Int Health. 2016 Jan; 21(1):18-27. PMID: 26485172.
    View in: PubMed
  21. Iketleng T, Moyo S, Gaseitsiwe S, Nyombi B, Mitchell RM, Makhema J, Baum MK, Marlink R, Essex M, Musonda R. Plasma Cytokine Levels in Chronic Asymptomatic HIV-1 Subtype C Infection as an Indicator of Disease Progression in Botswana: A Retrospective Case Control Study. AIDS Res Hum Retroviruses. 2016 Apr; 32(4):364-9. PMID: 26414751.
    View in: PubMed
  22. Schaan MM, Taylor M, Gungqisa N, Marlink R. Personal views about womanhood amongst women living with HIV in Botswana. Cult Health Sex. 2016; 18(2):173-85. PMID: 26305285.
    View in: PubMed
  23. Anderson M, Gaseitsiwe S, Moyo S, Wessels MJ, Mohammed T, Sebunya TK, Powell EA, Makhema J, Blackard JT, Marlink R, Essex M, Musonda RM. Molecular characterisation of hepatitis B virus in HIV-1 subtype C infected patients in Botswana. BMC Infect Dis. 2015 Aug 13; 15:335. PMID: 26268355; PMCID: PMC4535680.
  24. Auld AF, Agolory SG, Shiraishi RW, Wabwire-Mangen F, Kwesigabo G, Mulenga M, Hachizovu S, Asadu E, Tuho MZ, Ettiegne-Traore V, Mbofana F, Okello V, Azih C, Denison JA, Tsui S, Koole O, Kamiru H, Nuwagaba-Biribonwoha H, Alfredo C, Jobarteh K, Odafe S, Onotu D, Ekra KA, Kouakou JS, Ehrenkranz P, Bicego G, Torpey K, Mukadi YD, van Praag E, Menten J, Mastro T, Dukes Hamilton C, Swaminathan M, Dokubo EK, Baughman AL, Spira T, Colebunders R, Bangsberg D, Marlink R, Zee A, Kaplan J, Ellerbrock TV. Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults--seven African countries, 2004-2013. MMWR Morb Mortal Wkly Rep. 2014 Nov 28; 63(47):1097-103. PMID: 25426651.
    View in: PubMed
  25. Auld AF, Tuho MZ, Ekra KA, Shiraishi RW, Mohamed F, Kouakou JS, Ettiègne-Traoré V, Sabatier J, Essombo J, Rivadeneira ED, Adjorlolo-Johnson G, Marlink R, Ellerbrock TV. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program. Pediatr Infect Dis J. 2014 Nov; 33(11):1134-40. PMID: 25093975.
    View in: PubMed
  26. Liu KC, Farahani M, Mashamba T, Mawela M, Joseph J, Van Schaik N, Honey E, Gill M, Jassat W, Stringer EM, Chintu N, Marlink RG. Pregnancy outcomes and birth defects from an antiretroviral drug safety study of women in South Africa and Zambia. AIDS. 2014 Sep 24; 28(15):2259-68. PMID: 25115319.
    View in: PubMed
  27. Schaan MM, Taylor M, Marlink R. Reproductive behaviour among women on antiretroviral therapy in Botswana: mismatched pregnancy plans and contraceptive use. Afr J AIDS Res. 2014 Sep; 13(3):305-11. PMID: 25388984.
    View in: PubMed
  28. Auld AF, Ekra KA, Shiraishi RW, Tuho MZ, Kouakou JS, Mohamed F, Ettiègne-Traoré V, Sabatier J, Essombo J, Adjorlolo-Johnson G, Marlink R, Ellerbrock TV. Temporal trends in treatment outcomes for HIV-1 and HIV-2-infected adults enrolled in Côte d'Ivoire's national antiretroviral therapy program. PLoS One. 2014; 9(5):e98183. PMID: 24866468; PMCID: PMC4035349.
  29. Auld AF, Tuho MZ, Ekra KA, Kouakou J, Shiraishi RW, Adjorlolo-Johnson G, Marlink R, Ellerbrock TV. Tuberculosis in human immunodeficiency virus-infected children starting antiretroviral therapy in Côte d'Ivoire. Int J Tuberc Lung Dis. 2014 Apr; 18(4):381-7. PMID: 24670690.
    View in: PubMed
  30. Farahani M, Vable A, Lebelonyane R, Seipone K, Anderson M, Avalos A, Chadborn T, Tilahun H, Roumis D, Moeti T, Musuka G, Busang L, Gaolathe T, Malefho KC, Marlink R. Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis. Lancet Glob Health. 2014 Jan; 2(1):e44-50. PMID: 25104635.
    View in: PubMed
  31. Baum MK, Campa A, Lai S, Sales Martinez S, Tsalaile L, Burns P, Farahani M, Li Y, van Widenfelt E, Page JB, Bussmann H, Fawzi WW, Moyo S, Makhema J, Thior I, Essex M, Marlink R. Effect of micronutrient supplementation on disease progression in asymptomatic, antiretroviral-naive, HIV-infected adults in Botswana: a randomized clinical trial. JAMA. 2013 Nov 27; 310(20):2154-63. PMID: 24281460; PMCID: PMC4347896.
  32. Moyo S, LeCuyer T, Wang R, Gaseitsiwe S, Weng J, Musonda R, Bussmann H, Mine M, Engelbrecht S, Makhema J, Marlink R, Baum MK, Novitsky V, Essex M. Evaluation of the false recent classification rates of multiassay algorithms in estimating HIV type 1 subtype C incidence. AIDS Res Hum Retroviruses. 2014 Jan; 30(1):29-36. PMID: 23937344; PMCID: PMC3887420.
  33. McDonald B, Moyo S, Gabaitiri L, Gaseitsiwe S, Bussmann H, Koethe JR, Musonda R, Makhema J, Novitsky V, Marlink RG, Wester CW, Essex M. Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial. AIDS Res Hum Retroviruses. 2013 Jul; 29(7):993-9. PMID: 23590237; PMCID: PMC3685692.
  34. Adjorlolo-Johnson G, Wahl Uheling A, Ramachandran S, Strasser S, Kouakou J, Tindyebwa D, Alons C, Neluheni T, Lee S, Marlink R. Scaling up pediatric HIV care and treatment in Africa: clinical site characteristics associated with favorable service utilization. J Acquir Immune Defic Syndr. 2013 Jan 01; 62(1):e7-e13. PMID: 22955053.
    View in: PubMed
  35. Mazzeo CI, Flanagan EH, Bobrow EA, Pitter CS, Marlink R. How the global call for elimination of pediatric HIV can support HIV-positive women to achieve their pregnancy intentions. Reprod Health Matters. 2012 Dec; 20(39 Suppl):90-102. PMID: 23177684.
    View in: PubMed
  36. Marlink R, El-Sadr W, Simao M, Katabira E. Engaging to end the epidemic: seven essential steps toward an AIDS-free generation. J Acquir Immune Defic Syndr. 2012 Aug 01; 60 Suppl 2:S19-21. PMID: 22772384.
    View in: PubMed
  37. Wester CW, Eden SK, Shepherd BE, Bussmann H, Novitsky V, Samuels DC, Hendrickson SL, Winkler CA, O'Brien SJ, Essex M, D'Aquila RT, DeGruttola V, Marlink RG. Risk factors for symptomatic hyperlactatemia and lactic acidosis among combination antiretroviral therapy-treated adults in Botswana: results from a clinical trial. AIDS Res Hum Retroviruses. 2012 Aug; 28(8):759-65. PMID: 22540188; PMCID: PMC3399551.
  38. Stephens LL, Bachhuber MA, Seloilwe E, Gungqisa N, Mmelesi M, Bussmann H, Marlink RG, Wester CW. HIV-Related knowledge, attitudes, and practice among educated young adults in Botswana. J AIDS HIV Res. 2012 Jun 01; 4(6):159-164. PMID: 23275859.
    View in: PubMed
  39. Schaan MM, Taylor M, Puvimanasinghe J, Busang L, Keapoletswe K, Marlink R. Sexual and reproductive health needs of HIV-positive women in Botswana - a study of health care worker's views. AIDS Care. 2012; 24(9):1120-5. PMID: 22568549.
    View in: PubMed
  40. Wester CW, Stitelman OM, deGruttola V, Bussmann H, Marlink RG, van der Laan MJ. Effect modification by sex and baseline CD4+ cell count among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial. AIDS Res Hum Retroviruses. 2012 Sep; 28(9):981-8. PMID: 22309114; PMCID: PMC3423643.
  41. Heidari S, Abdool Karim Q, Auerbach JD, Buitendijk SE, Cahn P, Curno MJ, Hankins C, Katabira E, Kippax S, Marlink R, Marsh J, Marusic A, Nass HM, Montaner J, Pollitzer E, Ruiz-Cantero MT, Sherr L, Sow PS, Squires K, Wainberg MA. Gender-sensitive reporting in medical research. J Int AIDS Soc. 2012 Mar 08; 15(1):11. PMID: 22400977; PMCID: PMC3313880.
  42. Heidari S, Mofenson LM, Hobbs CV, Cotton MF, Marlink R, Katabira E. Unresolved antiretroviral treatment management issues in HIV-infected children. J Acquir Immune Defic Syndr. 2012 Feb 01; 59(2):161-9. PMID: 22138766.
    View in: PubMed
  43. Mine M, Moyo S, Stevens P, Michael K, Novitsky V, Makhaola K, Asmelash A, Molefhabangwe S, Woldegabriel E, Mothowaeng G, Maruta T, Kamhukamwe C, Mangwendeza PM, Holmes-Pretorius M, Mtoni I, Motswaledi M, Musonda R, Ndwapi N, Makhema J, Marlink R, Seipone K, Gaolathe T, Essex M. Immunohaematological reference values for HIV-negative healthy adults in Botswana. Afr J Lab Med. 2012; 1(1). PMID: 23772402.
    View in: PubMed
  44. Mine M, Moyo S, Stevens P, Michael K, Novitsky V, Makhaola K, Asmelash A, Molefhabangwe S, Woldegabriel E, Mothowaeng G, Maruta T, Kamhukamwe C, Mangwendeza PM, Holmes-Pretorius M, Mtoni I, Motswaledi M, Musonda R, Ndwapi N, Makhema J, Marlink R, Seipone K, Gaolathe T, Essex M. Immunohaematological reference values for HIV-negative healthy adults in Botswana. Afr J Lab Med. 2012; 1(1):5. PMID: 29062725.
    View in: PubMed
  45. Moyo S, Bussmann H, Mangwendeza P, Dusara P, Gaolathe T, Mine M, Musonda R, van Widenfelt E, Novitsky V, Makhema J, Marlink RG, Essex M, Wester CW. Validation of A Point-of-Care Lactate Device For Screening At-Risk Adults Receiving Combination Antiretroviral Therapy In Botswana. J Antivir Antiretrovir. 2011 Oct; 3(4):45-48. PMID: 23087782.
    View in: PubMed
  46. Heidari S, Mofenson L, Cotton MF, Marlink R, Cahn P, Katabira E. Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children. J Acquir Immune Defic Syndr. 2011 Aug 01; 57(4):290-6. PMID: 21602695.
    View in: PubMed
  47. Wester CW, Koethe JR, Shepherd BE, Stinnette SE, Rebeiro PF, Kipp AM, Hong H, Bussmann H, Gaolathe T, McGowan CC, Sterling TR, Marlink RG. Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting. AIDS. 2011 Jul 31; 25(12):1471-9. PMID: 21572309; PMCID: PMC3188442.
  48. Bussmann H, de la Hoz Gomez F, Roels TH, Wester CW, Bodika SM, Moyo S, Taffa N, Anderson MG, Mine M, Bile EC, Yang C, Mphoyakgosi K, Lehotzky EA, Mlotshwa B, Mmelesi M, Seipone K, Makhema MJ, Marlink RG, Novitsky V, Essex M. Prevalence of transmitted HIV drug resistance in Botswana: lessons learned from the HIVDR-Threshold Survey conducted among women presenting for routine antenatal care as part of the 2007 national sentinel survey. AIDS Res Hum Retroviruses. 2011 Apr; 27(4):365-72. PMID: 21034246.
    View in: PubMed
  49. Do NT, Phiri K, Bussmann H, Gaolathe T, Marlink RG, Wester CW. Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana. AIDS Res Hum Retroviruses. 2010 Jun; 26(6):685-91. PMID: 20518649; PMCID: PMC4056458.
  50. Novitsky V, Wang R, Bussmann H, Lockman S, Baum M, Shapiro R, Thior I, Wester C, Wester CW, Ogwu A, Asmelash A, Musonda R, Campa A, Moyo S, van Widenfelt E, Mine M, Moffat C, Mmalane M, Makhema J, Marlink R, Gilbert P, Seage GR, DeGruttola V, Essex M. HIV-1 subtype C-infected individuals maintaining high viral load as potential targets for the "test-and-treat" approach to reduce HIV transmission. PLoS One. 2010 Apr 12; 5(4):e10148. PMID: 20405044; PMCID: PMC2853582.
  51. Wester CW, Thomas AM, Bussmann H, Moyo S, Makhema JM, Gaolathe T, Novitsky V, Essex M, deGruttola V, Marlink RG. Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana. AIDS. 2010 Jan; 24 Suppl 1:S27-36. PMID: 20023437; PMCID: PMC3087813.
  52. Wester CW, Bussmann H, Koethe J, Moffat C, Vermund S, Essex M, Marlink RG. Adult combination antiretroviral therapy in sub-Saharan Africa: lessons from Botswana and future challenges. HIV Ther. 2009 Sep 01; 3(5):501-526. PMID: 20161344.
    View in: PubMed
  53. Bussmann H, Wester CW, Thomas A, Novitsky V, Okezie R, Muzenda T, Gaolathe T, Ndwapi N, Mawoko N, Widenfelt E, Moyo S, Musonda R, Mine M, Makhema J, Moffat H, Essex M, Degruttola V, Marlink RG. Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial. J Acquir Immune Defic Syndr. 2009 May 01; 51(1):37-46. PMID: 19282782; PMCID: PMC3066172.
  54. Mine M, Bedi K, Maruta T, Madziva D, Tau M, Zana T, Gaolathe T, Moyo S, Seipone K, Ndwapi N, Essex M, Marlink R. Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study. J Virol Methods. 2009 Jul; 159(1):93-7. PMID: 19442851.
    View in: PubMed
  55. Bussmann H, Wester CW, Ndwapi N, Grundmann N, Gaolathe T, Puvimanasinghe J, Avalos A, Mine M, Seipone K, Essex M, Degruttola V, Marlink RG. Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program. AIDS. 2008 Nov 12; 22(17):2303-11. PMID: 18981769; PMCID: PMC2853026.
  56. Marlink R, Forsythe S, Bertozzi SM, Muirhead D, Holmes M, Sturchio J. The economic impacts of HIV/AIDS on households and economies. AIDS. 2008 Jul; 22 Suppl 1:S87-8. PMID: 18664959.
    View in: PubMed
  57. Moatti JP, Marlink R, Luchini S, Kazatchkine M. Universal access to HIV treatment in developing countries: going beyond the misinterpretations of the 'cost-effectiveness' algorithm. AIDS. 2008 Jul; 22 Suppl 1:S59-66. PMID: 18664955.
    View in: PubMed
  58. Marlink R, Forsythe S, Bertozzi SM, Muirhead D, Holmes M, Sturchio J. Informing scale-up and resource allocation: the use of economic analysis. AIDS. 2008 Jul; 22 Suppl 1:S5-6. PMID: 18664953.
    View in: PubMed
  59. Marlink R, Forsythe S, Bertozzi SM, Muirhead D, Holmes M, Sturchio J. Re: This special issue of AIDS--a mix of recent economic analyses and commentary on how best to distill economic insights to improve HIV/AIDS policies and programmes. AIDS. 2008 Jul; 22 Suppl 1:S1-4. PMID: 18664940.
    View in: PubMed
  60. Marlink R, Forsythe S, Bertozzi SM, Muirhead D, Holmes M, Sturchio J. Combining evidence for access to and benefits from antiretroviral treatment to inform planning. AIDS. 2008 Jul; 22 Suppl 1:S121-2. PMID: 18664943.
    View in: PubMed
  61. Toure S, Kouadio B, Seyler C, Traore M, Dakoury-Dogbo N, Duvignac J, Diakite N, Karcher S, Grundmann C, Marlink R, Dabis F, Anglaret X. Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants. AIDS. 2008 Apr 23; 22(7):873-82. PMID: 18427206; PMCID: PMC3921665.
  62. Bussmann C, Rotz P, Ndwapi N, Baxter D, Bussmann H, Wester CW, Ncube P, Avalos A, Mine M, Mabe E, Burns P, Cardiello P, Makhema J, Marlink R. Strengthening healthcare capacity through a responsive, country-specific, training standard: the KITSO AIDS training program's support of Botswana's national antiretroviral therapy rollout. Open AIDS J. 2008; 2:10-6. PMID: 18923699; PMCID: PMC2556202.
  63. Wester CW, Okezie OA, Thomas AM, Bussmann H, Moyo S, Muzenda T, Makhema J, van Widenfelt E, Musonda R, Novitsky V, Gaolathe T, Ndwapi N, Essex M, Kuritzkes DR, DeGruttola V, Marlink RG. Higher-than-expected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswana: preliminary results from a large randomized clinical trial. J Acquir Immune Defic Syndr. 2007 Nov 01; 46(3):318-22. PMID: 18090299.
    View in: PubMed
  64. Novitsky V, Wester CW, DeGruttola V, Bussmann H, Gaseitsiwe S, Thomas A, Moyo S, Musonda R, Van Widenfelt E, Marlink RG, Essex M. The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa. AIDS Res Hum Retroviruses. 2007 Jul; 23(7):868-78. PMID: 17678469.
    View in: PubMed
  65. Bussmann H, Wester CW, Wester CN, Lekoko B, Okezie O, Thomas AM, DeGruttola SM, Makhema J, Essex M, Marlink RG. Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana. J Acquir Immune Defic Syndr. 2007 Jul 01; 45(3):269-73. PMID: 17450102.
    View in: PubMed
  66. Wester CW, Bussmann H, Moyo S, Avalos A, Gaolathe T, Ndwapi N, Essex M, MacGregor RR, Marlink RG. Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana. Clin Infect Dis. 2006 Dec 15; 43(12):1612-5. PMID: 17109297.
    View in: PubMed
  67. Wolfe WR, Weiser SD, Bangsberg DR, Thior I, Makhema JM, Dickinson DB, Mompati KF, Marlink RG. Effects of HIV-related stigma among an early sample of patients receiving antiretroviral therapy in Botswana. AIDS Care. 2006 Nov; 18(8):931-3. PMID: 17012082.
    View in: PubMed
  68. Thior I, Gabaitiri L, Grimes J, Shapiro R, Lockman S, Kim S, Kebaabetswe P, Garmey E, Montano M, Peter T, Chang SY, Marlink R, Essex M. Voluntary counseling and testing among post-partum women in Botswana. Patient Educ Couns. 2007 Mar; 65(3):296-302. PMID: 17029865; PMCID: PMC1868467.
  69. Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, Stevens L, Peter T, Kim S, van Widenfelt E, Moffat C, Ndase P, Arimi P, Kebaabetswe P, Mazonde P, Makhema J, McIntosh K, Novitsky V, Lee TH, Marlink R, Lagakos S, Essex M. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA. 2006 Aug 16; 296(7):794-805. PMID: 16905785.
    View in: PubMed
  70. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, Mtonga V, Reid S, Cantrell RA, Bulterys M, Saag MS, Marlink RG, Mwinga A, Ellerbrock TV, Sinkala M. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006 Aug 16; 296(7):782-93. PMID: 16905784.
    View in: PubMed
  71. Bussmann H, Wester CW, Ndwapi N, Vanderwarker C, Gaolathe T, Tirelo G, Avalos A, Moffat H, Marlink RG. Hybrid data capture for monitoring patients on highly active antiretroviral therapy (HAART) in urban Botswana. Bull World Health Organ. 2006 Feb; 84(2):127-31. PMID: 16501730; PMCID: PMC2626532.
  72. Wester CW, Kim S, Bussmann H, Avalos A, Ndwapi N, Peter TF, Gaolathe T, Mujugira A, Busang L, Vanderwarker C, Cardiello P, Johnson O, Thior I, Mazonde P, Moffat H, Essex M, Marlink R. Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana. J Acquir Immune Defic Syndr. 2005 Nov 01; 40(3):336-43. PMID: 16249709.
    View in: PubMed
  73. Wester CW, Bussmann H, Avalos A, Ndwapi N, Gaolathe T, Cardiello P, Bussmann C, Moffat H, Mazonde P, Marlink RG. Establishment of a public antiretroviral treatment clinic for adults in urban Botswana: lessons learned. Clin Infect Dis. 2005 Apr 01; 40(7):1041-4. PMID: 15824998.
    View in: PubMed
  74. Bussmann H, Novitsky V, Wester W, Peter T, Masupu K, Gabaitiri L, Kim S, Gaseitsiwe S, Ndungú T, Marlink R, Thior I, Essex M. HIV-1 subtype C drug-resistance background among ARV-naive adults in Botswana. Antivir Chem Chemother. 2005; 16(2):103-15. PMID: 15889533.
    View in: PubMed
  75. Bussmann H, Wester CW, Masupu KV, Peter T, Gaolekwe SM, Kim S, Reich AM, Ahn S, Wu Y, Thior I, Essex M, Marlink R. Low CD4+ T-lymphocyte values in human immunodeficiency virus-negative adults in Botswana. Clin Diagn Lab Immunol. 2004 Sep; 11(5):930-5. PMID: 15358655; PMCID: PMC515279.
  76. Doualla-Bell F, Gaseitsiwe S, Ndungú T, Modukanele M, Peter T, Novitsky V, Ndwapi N, Tendani G, Avalos A, Wester W, Bussmann H, Cardiello P, Marlink R, Moffat H, Thior I, Wainberg MA, Essex M. Mutations and polymorphisms associated with antiretroviral drugs in HIV-1C-infected African patients. Antivir Chem Chemother. 2004 Jul; 15(4):189-200. PMID: 15457680.
    View in: PubMed
  77. Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, Kebaabetswe P, Dickenson D, Mompati K, Essex M, Marlink R. Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana. J Acquir Immune Defic Syndr. 2003 Nov 01; 34(3):281-8. PMID: 14600572.
    View in: PubMed
  78. Quan Y, Brenner BG, Marlink RG, Essex M, Kurimura T, Wainberg MA. Drug resistance profiles of recombinant reverse transcriptases from human immunodeficiency virus type 1 subtypes A/E, B, and C. AIDS Res Hum Retroviruses. 2003 Sep; 19(9):743-53. PMID: 14585205.
    View in: PubMed
  79. Shapiro RL, Lockman S, Thior I, Stocking L, Kebaabetswe P, Wester C, Peter T, Marlink R, Essex M, Heymann SJ. Low adherence to recommended infant feeding strategies among HIV-infected women: results from the pilot phase of a randomized trial to prevent mother-to-child transmission in Botswana. AIDS Educ Prev. 2003 Jun; 15(3):221-30. PMID: 12866834.
    View in: PubMed
  80. Brenner B, Turner D, Oliveira M, Moisi D, Detorio M, Carobene M, Marlink RG, Schapiro J, Roger M, Wainberg MA. A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors. AIDS. 2003 Jan 03; 17(1):F1-5. PMID: 12478089.
    View in: PubMed
  81. Novitsky V, Gilbert P, Peter T, McLane MF, Gaolekwe S, Rybak N, Thior I, Ndung'u T, Marlink R, Lee TH, Essex M. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J Virol. 2003 Jan; 77(2):882-90. PMID: 12502804; PMCID: PMC140844.
  82. Novitsky V, Cao H, Rybak N, Gilbert P, McLane MF, Gaolekwe S, Peter T, Thior I, Ndung'u T, Marlink R, Lee TH, Essex M. Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C. J Virol. 2002 Oct; 76(20):10155-68. PMID: 12239290; PMCID: PMC136554.
  83. Gruskin S, Ayres JR, Khamranksi B, Lalloo U, Marlink R. GAVI, the first steps: lessons for the Global Fund. Lancet. 2002 Jul 13; 360(9327):176. PMID: 12126856.
    View in: PubMed
  84. Novitsky V, Smith UR, Gilbert P, McLane MF, Chigwedere P, Williamson C, Ndung'u T, Klein I, Chang SY, Peter T, Thior I, Foley BT, Gaolekwe S, Rybak N, Gaseitsiwe S, Vannberg F, Marlink R, Lee TH, Essex M. Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design? J Virol. 2002 Jun; 76(11):5435-51. PMID: 11991972; PMCID: PMC137027.
  85. Novitsky V, Rybak N, McLane MF, Gilbert P, Chigwedere P, Klein I, Gaolekwe S, Chang SY, Peter T, Thior I, Ndung'u T, Vannberg F, Foley BT, Marlink R, Lee TH, Essex M. Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design. J Virol. 2001 Oct; 75(19):9210-28. PMID: 11533184; PMCID: PMC114489.
  86. Novitsky V, Flores-Villanueva PO, Chigwedere P, Gaolekwe S, Bussman H, Sebetso G, Marlink R, Yunis EJ, Essex M. Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design. Hum Immunol. 2001 Feb; 62(2):146-56. PMID: 11182225.
    View in: PubMed
  87. Marlink R, Kao H, Hsieh E. Clinical care issues for women living with HIV and AIDS in the United States. AIDS Res Hum Retroviruses. 2001 Jan 01; 17(1):1-33. PMID: 11177380.
    View in: PubMed
  88. Novitsky VA, Gaolekwe S, McLane MF, Ndung'u TP, Foley BT, Vannberg F, Marlink R, Essex M. HIV type 1 A/J recombinant with a pronounced pol gene mosaicism. AIDS Res Hum Retroviruses. 2000 Jul 01; 16(10):1015-20. PMID: 10890363.
    View in: PubMed
  89. Novitsky VA, Montano MA, McLane MF, Renjifo B, Vannberg F, Foley BT, Ndung'u TP, Rahman M, Makhema MJ, Marlink R, Essex M. Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana. J Virol. 1999 May; 73(5):4427-32. PMID: 10196340; PMCID: PMC104223.
  90. Sarr AD, Popper S, Thior I, Hamel DJ, Sankalé JL, Siby T, Marlink R, Essex M, Mboup S, Kanki P. Relation between HIV-2 proviral load and CD4+ lymphocyte count differs in monotypic and dual HIV infections. J Hum Virol. 1999 Jan-Feb; 2(1):45-51. PMID: 10200599.
    View in: PubMed
  91. Kanki PJ, Hamel DJ, Sankalé JL, Hsieh Cc, Thior I, Barin F, Woodcock SA, Guèye-Ndiaye A, Zhang E, Montano M, Siby T, Marlink R, NDoye I, Essex ME, MBoup S. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis. 1999 Jan; 179(1):68-73. PMID: 9841824.
    View in: PubMed
  92. Popper SJ, Sankalé JL, Thior I, Siby T, Marlink RG, Mboup S, Essex M, Kanki PJ. Antibodies to the HIV type 2 core protein p26 and Vpx: association with disease progression. AIDS Res Hum Retroviruses. 1998 Sep 01; 14(13):1157-62. PMID: 9737587.
    View in: PubMed
  93. Travers KU, Eisen GE, Marlink RG, Essex ME, Hsieh CC, Mboup S, Kanki PJ. Protection from HIV-1 infection by HIV-2. AIDS. 1998 Jan 22; 12(2):224-5. PMID: 9468377.
    View in: PubMed
  94. Sarr AD, Hamel DJ, Thior I, Kokkotou E, Sankalé JL, Marlink RG, Coll-Seck EM, Essex ME, Siby T, NDoye I, Mboup S, Kanki PJ. HIV-1 and HIV-2 dual infection: lack of HIV-2 provirus correlates with low CD4+ lymphocyte counts. AIDS. 1998 Jan 22; 12(2):131-7. PMID: 9468361.
    View in: PubMed
  95. Marlink R. Achieving an HIV vaccine: the need for an accelerated national campaign. J Int Assoc Physicians AIDS Care. 1997 Nov; 3(11):35-7. PMID: 11364812.
    View in: PubMed
  96. Thior I, Diouf G, Diaw IK, Sarr AD, Hsieh CC, Ndoye I, Mboup S, Chen L, Essex M, Marlink R, Kanki P. Sexually transmitted diseases and risk of HIV infection in men attending a sexually transmitted diseases clinic in Dakar, Senegal. Afr J Reprod Health. 1997 Sep; 1(2):26-35. PMID: 10214412.
    View in: PubMed
  97. Sankalé JL, De La Tour RS, Marlink RG, Scheib R, Mboup S, Essex ME, Kanki PJ. Distinct quasi-species in the blood and the brain of an HIV-2-infected individual. Virology. 1996 Dec 15; 226(2):418-23. PMID: 8955063.
    View in: PubMed
  98. Kanki PJ, Eisen G, Travers KU, Marlink RG, Essex ME, Hsieh CC, Mboup S. Response: HIV-2 and Natural Protection Against HIV-1 Infection. Science. 1996 Jun 28; 272(5270):1959b-60b. PMID: 17774134.
    View in: PubMed
  99. Dooneief G, Marlink R, Bell K, Marder K, Renjifo B, Stern Y, Mayeux R. Neurologic consequences of HTLV-II infection in injection-drug users. Neurology. 1996 Jun; 46(6):1556-60. PMID: 8649548.
    View in: PubMed
  100. Marlink R. Lessons from the second AIDS virus, HIV-2. AIDS. 1996 Jun; 10(7):689-99. PMID: 8805859.
    View in: PubMed
  101. Soto-Ramirez LE, Renjifo B, McLane MF, Marlink R, O'Hara C, Sutthent R, Wasi C, Vithayasai P, Vithayasai V, Apichartpiyakul C, Auewarakul P, Peña Cruz V, Chui DS, Osathanondh R, Mayer K, Lee TH, Essex M. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science. 1996 Mar 01; 271(5253):1291-3. PMID: 8638113.
    View in: PubMed
  102. Travers K, Mboup S, Marlink R, Guèye-Nidaye A, Siby T, Thior I, Traore I, Dieng-Sarr A, Sankalé JL, Mullins C, et al. Natural protection against HIV-1 infection provided by HIV-2. Science. 1995 Jun 16; 268(5217):1612-5. PMID: 7539936.
    View in: PubMed
  103. Sankalé JL, de la Tour RS, Renjifo B, Siby T, Mboup S, Marlink RG, Essex ME, Kanki PJ. Intrapatient variability of the human immunodeficiency virus type 2 envelope V3 loop. AIDS Res Hum Retroviruses. 1995 May; 11(5):617-23. PMID: 7576918.
    View in: PubMed
  104. Dangond F, Daza JS, Rosania A, Quin MJ, Zaninovic V, Chaplin B, Marlink R, Hafler DA. Tropical spastic paraparesis on the Caribbean coast of Colombia. Am J Trop Med Hyg. 1995 Feb; 52(2):155-8. PMID: 7872443.
    View in: PubMed
  105. Soto-Ramirez LE, Garcia-Vallejo F, Renjifo B, Vergara A, Borrero I, Marlink R, Essex M. Human T-lymphotropic virus type I (HTLV-I)-specific antibodies and cell-free RNA in crevicular fluid-rich saliva from patients with tropical spastic paraparesis/HTLV-I-associated myelopathy. Viral Immunol. 1995; 8(3):141-50. PMID: 8833267.
    View in: PubMed
  106. Marlink R, Kanki P, Thior I, Travers K, Eisen G, Siby T, Traore I, Hsieh CC, Dia MC, Gueye EH, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science. 1994 Sep 09; 265(5178):1587-90. PMID: 7915856.
    View in: PubMed
  107. Kanki PJ, Travers KU, MBoup S, Hsieh CC, Marlink RG, Gueye-NDiaye A, Siby T, Thior I, Hernandez-Avila M, Sankalé JL, et al. Slower heterosexual spread of HIV-2 than HIV-1. Lancet. 1994 Apr 16; 343(8903):943-6. PMID: 7909009.
    View in: PubMed
  108. Kashala O, Marlink R, Ilunga M, Diese M, Gormus B, Xu K, Mukeba P, Kasongo K, Essex M. Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan. J Infect Dis. 1994 Feb; 169(2):296-304. PMID: 7906291.
    View in: PubMed
  109. Di Franco MJ, Marlink R, Hunter DJ, Tosteson T, Mayer K, Essex M. Association of immune activation with intravenous heroin use and methadone treatment in HIV-1 seropositive and seronegative subjects. J Acquir Immune Defic Syndr. 1993 Dec; 6(12):1297-300. PMID: 8254465.
    View in: PubMed
  110. Guèye-Ndiaye A, Clark RJ, Samuel KP, Ndour-Sarr AN, Ouangré A, Sangaré L, Mboup S, Marlink RG, Papas TS, Child RH, et al. Cost-effective diagnosis of HIV-1 and HIV-2 by recombinant-expressed env peptide (566/996) dot-blot analysis. AIDS. 1993 Apr; 7(4):475-81. PMID: 8507413.
    View in: PubMed
  111. Sow PS, Diouf G, Diop BM, Mboup A, Wangre A, Marlink R, Ndir O, Coll-Seck AM. [Preliminary study of pneumocystis carinii pneumonia diagnosed by induced expectoration in HIV positive patients in Dakar]. Dakar Med. 1993; 38(2):115-8. PMID: 7758366.
    View in: PubMed
  112. Maayan S, Dan M, Marlink R, Chen YM. HTLV among Israeli intravenous drug abusers. Int J Epidemiol. 1992 Oct; 21(5):995-7. PMID: 1468865.
    View in: PubMed
  113. Kanki P, M'Boup S, Marlink R, Travers K, Hsieh CC, Gueye A, Boye C, Sankalé JL, Donnelly C, Leisenring W, et al. Prevalence and risk determinants of human immunodeficiency virus type 2 (HIV-2) and human immunodeficiency virus type 1 (HIV-1) in west African female prostitutes. Am J Epidemiol. 1992 Oct 01; 136(7):895-907. PMID: 1442755.
    View in: PubMed
  114. Essex M, Kanki PJ, Marlink R, Chou MJ, Lee TH. Antigenic characterization of the human immunodeficiency viruses. J Am Acad Dermatol. 1990 Jun; 22(6 Pt 2):1206-10. PMID: 2193947.
    View in: PubMed
  115. Marlink RG, Lokich JJ, Robins JR, Clouse ME. Hepatic arterial embolization for metastatic hormone-secreting tumors. Technique, effectiveness, and complications. Cancer. 1990 May 15; 65(10):2227-32. PMID: 2161278.
    View in: PubMed
  116. Hellinger J, Marlink R, Kaptue L, Zekeng L, Essex M. Are tuberculosis patients a 'sentinel' population for HIV epidemic in Africa? Trans R Soc Trop Med Hyg. 1990 Mar-Apr; 84(2):292. PMID: 2389324.
    View in: PubMed
  117. Romieu I, Marlink R, Kanki P, M'Boup S, Essex M. HIV-2 link to AIDS in West Africa. J Acquir Immune Defic Syndr. 1990; 3(3):220-30. PMID: 2406413.
    View in: PubMed
  118. Ayanian JZ, Maguire JH, Marlink RG, Essex M, Kanki PJ. HIV-2 infection in the United States. N Engl J Med. 1989 May 25; 320(21):1422-3. PMID: 2716792.
    View in: PubMed
  119. Marlink RG, Ricard D, M'Boup S, Kanki PJ, Romet-Lemonne JL, N'Doye I, Diop K, Simpson MA, Greco F, Chou MJ, et al. Clinical, hematologic, and immunologic cross-sectional evaluation of individuals exposed to human immunodeficiency virus type-2 (HIV-2). AIDS Res Hum Retroviruses. 1988 Apr; 4(2):137-48. PMID: 3259142.
    View in: PubMed
  120. Kanki PJ, M'Boup S, Ricard D, Barin F, Denis F, Boye C, Sangare L, Travers K, Albaum M, Marlink R, et al. Human T-lymphotropic virus type 4 and the human immunodeficiency virus in West Africa. Science. 1987 May 15; 236(4803):827-31. PMID: 3033826.
    View in: PubMed
  121. Marlink RG, Essex M. Africa and the biology of human immunodeficiency virus. JAMA. 1987 May 15; 257(19):2632-3. PMID: 3494858.
    View in: PubMed
  122. Marlink R, Anderson K, Essex M, Groopman J. Transfusion-acquired HIV infection among immunocompromised hosts. Haematol Blood Transfus. 1987; 31:410-3. PMID: 3481757.
    View in: PubMed
  123. Marlink RG, Allan JS, McLane MF, Essex M, Anderson KC, Groopman JE. Low sensitivity of ELISA testing in early HIV infection. N Engl J Med. 1986 Dec 11; 315(24):1549. PMID: 3466032.
    View in: PubMed
  124. Anderson KC, Gorgone BC, Marlink RG, Ferriani R, Essex ME, Benz PM, Groopman JE. Transfusion-acquired human immunodeficiency virus infection among immunocompromised persons. Ann Intern Med. 1986 Oct; 105(4):519-27. PMID: 3019200.
    View in: PubMed
  125. Zibrak JD, Silvestri RC, Costello P, Marlink R, Jensen WA, Robins A, Rose RM. Bronchoscopic and radiologic features of Kaposi's sarcoma involving the respiratory system. Chest. 1986 Oct; 90(4):476-9. PMID: 3489584.
    View in: PubMed
  126. Marlink R, Allan J, Essex M. Unusual serological profiles in AIDS. Lancet. 1986 Jun 14; 1(8494):1389. PMID: 2872505.
    View in: PubMed
  127. Kanki PJ, Barin F, M'Boup S, Allan JS, Romet-Lemonne JL, Marlink R, McLane MF, Lee TH, Arbeille B, Denis F, et al. New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM). Science. 1986 Apr 11; 232(4747):238-43. PMID: 3006256.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Marlink's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (414)
Explore
_
Co-Authors (37)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_